Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Net Margin (2020 - 2025)

Bioventus' Net Margin history spans 5 years, with the latest figure at 10.97% for Q4 2025.

  • For Q4 2025, Net Margin changed N/A year-over-year to 10.97%; the TTM value through Dec 2025 reached 4.8%, changed N/A, while the annual FY2023 figure was 14.53%, 110.0% down from the prior year.
  • Net Margin reached 10.97% in Q4 2025 per BVS's latest filing, up from 2.89% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 29.99% in Q2 2021 to a low of 62.51% in Q2 2023.
  • Average Net Margin over 4 years is 6.22%, with a median of 0.34% recorded in 2022.
  • Peak YoY movement for Net Margin: soared 1666bps in 2021, then tumbled -6217bps in 2023.
  • A 4-year view of Net Margin shows it stood at 0.02% in 2021, then crashed by -96890bps to 18.59% in 2022, then plummeted by -236bps to 62.51% in 2023, then soared by 118bps to 10.97% in 2025.
  • Per Business Quant, the three most recent readings for BVS's Net Margin are 10.97% (Q4 2025), 2.89% (Q3 2025), and 6.28% (Q2 2025).